Surmodics Reports Third Quarter Fiscal 2018 Results

Go back to Surmodics Reports Third Quarter Fiscal 2018 Results

SurModics (SRDX) PT Raised to $74 at Needham & Company

August 6, 2018 1:44 PM EDT

Needham & Company raised its price target on SurModics (NASDAQ: SRDX) to $74.00 (from $55.00) while maintaining a Buy rating.

Analyst Mike Matson commented, "SRDX beat consensus F3Q18 revenue and EPS. Management raised its FY18 revenue and adjusted EPS guidance. Revenue growth... More

SurModics (SRDX) Reports Q3 EPS of $0.27, Revenues Beat; 'Raising Fiscal 2018 Revenue & EPS Guidance'

August 6, 2018 7:32 AM EDT

SurModics (NASDAQ: SRDX) reported Q3 EPS of $0.27, versus ($0.24) reported last year. Revenue for the quarter came in at $22.2 million versus the consensus estimate of $19.38 million.

Summary of Third Quarter Fiscal 2018 and Recent Highlights

Revenue of $22.2 million, up 24.9%Raising revenue guidance range to $79.0 to $81.0 millionGAAP EPS of ($0.20), Non-GAAP EPS of $0.27Acquisition... More